Cole Eye Institute, Cleveland Clinic Foundation,

Slides:



Advertisements
Similar presentations
AMD Trials and Treatments:
Advertisements

Randomized Trial Evaluating Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema: Potential impact of.
Ocular plastic causes of the irritated eye Geoff Wilcsek.
Familial corneal patterns in pellucid marginal degeneration: uncovering a possible etiology Hajirah N. Saeed, MD.
Chapter 34 Pressure Ulcers
Mohd Shafiq Bin Paridin Mohd. Firdaus Bin Jamalullail Nik Mohd Abduh Bin Nik Mhd Nor 4 th Year Medical Student Faculty Of Medicine, Zagazig University.
Physician Compliance With the HEDS Recommendation of Antiviral Prophylaxis in Patients Diagnosed With Herpetic Stromal Keratitis at KEI Sameen Zaidi M.D.
Incidence of Blepharitis in Patients Undergoing Phacoemulsification Jodi Luchs, MD Carlos Buznego, MD William Trattler, MD The authors of this poster have.
Delay in Symptom Resolution After Thermal Pulsation System Treatment for Meibomian Gland Dysfunction in Dry-Eye Disease Delay in Symptom Resolution After.
Non-Invasive Keratograph Tear Break-Up Time versus Invasive Fluorescein-Associated Tear Stability Test: Experimental Validation Study Nizar S Abdelfattah,
Impact of Conjunctivochalasis in Dry Eye
Epitheliopathy in the Region of the Eyelid Associated with the Caruncle in Normal Subjects and Dry-Eye Patients Epitheliopathy in the Region of the Eyelid.
Health-related quality of life in diabetic patients and controls without diabetes in refugee camps in Gaza strip: a cross-sectional study By: Ashraf Eljedi:
Yousef A Alghamdi, MD; Allison L McClellan, OD; Nabeel M Shalabi, MD Anat Galor, MD, MSPH Supported by the Department of Veterans Affairs, Veterans Health.
OPHTHALMOLOGY UPDATE Ajay Bhatnagar Consultant Ophthalmologist
Lower Extremity Venous Disease: Peripheral Venous Insufficiency
1. Vision Changes  You may notice vision changes with aging.  Many changes are common and can often be corrected.  As you get older, you are at higher.
Long term ocular manifestations of Stevens-Johnson syndrome and toxic epidermal necrolysis in children Asim Ali, MD, FRCSC Kamiar Mireskandari, MD,
W. B. Trattler; C. D. Reilly; D. F. Goldberg; P. A. Majmudar; J. A. Vukich; M. Packer; E. D. Donnenfeld.
® Introduction Mental Health Predictors of Pain and Function in Patients with Chronic Low Back Pain Olivia D. Lara, K. Ashok Kumar MD FRCS Sandra Burge,
Blepharitis and Dry eyes in Aromatase Inhibitor Users Kiran Turaka, M.D. Kristin M. Hammersmith, M.D. Jennifer M. Nottage, M.D. Christopher J. Rapuano,
How The Eye Works Insert name/ Practice name/ Logo here if desired.
Alzheimer’s patients Caregivers Survey in Greece Dr Paraskevi Sakka Neuropsychiatrist Chairwoman, Athens Association of Alzheimer’s Disease and Related.
Association between Depression And Dry eye Sang Beom Han, MD, 1 Joon Young Hyon, MD, 1 Young Joo Shin, MD, 1 Won Ryang Wee, MD, 2 Jin Hak Lee, MD, 1 1.
Blepharitis and Dry eyes in Aromatase Inhibitor Users
Results of Intraductal Meibomian Gland Probing (MGP) for Symptoms of Inflammatory Meibomian Gland Dysfunction (MGD) Excluding Lid Tenderness Steven L.
Bepotastine Besilate Ophthalmic Solution 1.5% and Degree of Reduced Ocular Itching in a Conjunctival Allergen Challenge Test JI Williams 1, G Torkildsen.
Effects of Xalatan® (latanoprost) or Travatan® (travoprost) on Ocular Surface Signs and Symptoms in Ocular Hypertensive or Glaucoma Patients. M.B. McDonald1,
® From Bad to Worse: Comorbidities and Chronic Lower Back Pain Margaret Cecere JD, Richard Young MD, Sandra Burge PhD The University of Texas Health Science.
Copyright restrictions may apply JAMA Ophthalmology Journal Club Slides: Effects of Azithromycin in Patients With Meibomian Gland Disease Zhang L, Su Z,
The Role of Thromboprophylaxis in Elective Spinal Surgery The Role of Thromboprophylaxis in Elective Spinal Surgery VA Elwell, N Koo Ng, D Horner & D Peterson.
Real-World Assessment of Clinical Outcomes in Lower-Risk Myelofibrosis Patients Receiving Treatment with Ruxolitinib Davis KL et al. Proc ASH 2014;Abstract.
Comparison of Bromfenac vs. Ketorolac During the Induction Phase of Treatment with Topical Cyclosporine for Dry Eye Patients Barry A. Schechter, MD Florida.
Vision related quality of life in persons with Dry eye syndrome using the 25 item National eye Institute visual function questionnaire S.P. Mahesh MD Janine.
Blepharitis and Dry eyes in Aromatase Inhibitor Users Kiran Turaka, M.D. Kristin M. Hammersmith, M.D. Jennifer M. Nottage, M.D. Christopher J. Rapuano,
® Introduction Changes in Opioid Use for Chronic Low Back Pain: One-Year Followup Roy X. Luo, Tamara Armstrong, PsyD, Sandra K. Burge, PhD The University.
Evaluation of Systane® versus Placebo in Corneal Epithelial Healing Following Photorefractive Keratectomy (PRK) Lt Col Charles D. Reilly Major Vasudha.
Phase IIIb Randomized, Double-Masked, Sham-Controlled Trial of Ranibizumab for Neovascular Age-related Macular Degeneration PIER Study Year 1 Regillo CD,
Prospective Correlation of Symptoms and Clinical Grading in Vernal Keratoconjunctivitis Patients Srikant K Sahu, Shraddha Pawan Sureka, Sujata Das, Apurva.
A Randomized Trial of Peribulbar Triamcinolone Acetonide with and without Focal Photocoagulation for Mild Diabetic Macular Edema: A Pilot Study.
Intraductal Meibomian Gland Probing for Meibomian Gland Dysfunction Using VAS Testing (updated ) DISCLOSURE: Patent Pending Class One Device Made.
David R. Hardten 1, Mark Milner 2, Jai G. Parekh 3, Neda Shamie 4, Darrell E. White 5 and Michael Schiewe 6 Financial Disclosures: Dr’s Hardten, Milner,
Prevalence of Dry Eye Disease among Elderly Korean Population Sang Beom Han, MD, 1 Joon Young Hyon, MD, 1 Won Ryang Wee, MD, 2,3 Jin Hak Lee, MD, 1, 3.
Copyright restrictions may apply JAMA Ophthalmology Journal Club Slides: AMD in the Age-Related Eye Disease Study Chew EY, Clemons TE, Agrón E, et al;
Mark Dacey MD, Brian Sullivan MD, and Steven Verity MD University of Texas Southwestern Medical Center and VA Medical Center, Dallas, TX None of the authors.
Blindness or low vision effects more than 3 million Americans 40 years and older, and this number is projected to reach 5.5 million by In addition.
Topical Cyclosporine 0.05% as a Long-Term Monotherapy for Atopic Keratoconjunctivitis Jonathan H. Tzu, M.D ¹, * ; C. Asli Utine, M.D ¹,², * Michael Stern,
After Cataract Surgery…
Familial corneal patterns in pellucid marginal degeneration: uncovering a possible etiology Hajirah N. Saeed, M.D., Amy B. Rosenfeld Ph.D., Xiaowu Gai,
Comparison of Efficacy of 0.05% Cyclosporine Ophthalmic Emulsion
RED EYE SYNDROM.
Efficacy of Topical Azithromycin & Cyclosporine A(CsA) vs CsA Alone in the Treatment of Dry Eyes Associated with Blepharitis Kenneth A. Beckman, M.D.,
The Diabetic Retinopathy Clinical Research Network DRCR.net Prompt PRP vs Ranibizumab+Deferred PRP for PDR Study Jeffrey G. Gross, M.D. – Protocol Chair.
mild Decompression for the Treatment of Lumbar Spinal Stenosis
Varicose Veins Power point by: Laurie Harriet Amber Gabby.
Old Fibrotic Vascular tissue in End-Stage Proliferative Retinopathy
THE PAINFUL RED EYE PART 1 DIAGNOSTIC APPROACH Lorrimer Esselaar.
Jason R. Miller, OD, MBA, FAAO
Risk of post-operative stroke in patients with known extra-cranial carotid artery disease undergoing Non-Cardiac Surgery Heart and Vascular.
Jodi Luchs, MD Carlos Buznego, MD William Trattler, MD
Caring Your Vision - Special Aspects
Efficacy of Subconjunctival Bevacizumab
Yumiko Ban,1,2,3) Seika Den,2) Jun Shimazaki,2,3)
Southern College of Optometry
ASCRS, San Francisco, CA, April 3-8, 2009
Clinical Case Symptomatic CVD without varicose veins
JAMA Ophthalmology Journal Club Slides: Effects of Azithromycin in Patients With Meibomian Gland Disease Zhang L, Su Z, Zhang Z, Lin J, Li D-Q, Pflugfelder.
MECS Peer Discussion.
Punctual plug and dry eye after photorefractive keratectomy
I-Chan Lin MD, Paul P. Lee MD, JD
Presentation transcript:

Cole Eye Institute, Cleveland Clinic Foundation, Prevalence of Blepharitis Signs and Symptoms Amongst Patients With Age Related Macular Degeneration. Rishi P. Singh, MD Cole Eye Institute, Cleveland Clinic Foundation, Cleveland Ohio Financial Disclosure: The author is a consultant to Oraya Therapeutics, Inspire, Alcon, and Genentech. 1

Purpose It has been recommended that prior to intravitreal injections, the ophthalmologist should identify and treat patients with comorbidities that predispose to endophthalmitis, specifically patients with active blepharitis. However, little is known on the rates of blepharitis within this treatment population. The purpose of this study is to determine the rates of anterior blepharitis amongst patients eligible for intravitreal injection for age related macular degeneration. 2

Methods In this IRB approved study, patients with both dry and wet AMD were assessed for frequency of common ocular surface symptoms associated with blepharitis with a self-reported survey. The patients scored their responses on a scale of 0-4 (0-no symptoms, 1-mild, 2-moderate, 3-severe, 4-very severe). The masked investigator also performed a clinical examination scored both eyes for signs of blepharitis. 3

Methods: Self Reported Patient Questions Eyelid itching: Do your eyelids feel itchy? (0) None: My eyelids do not feel itchy. (1) Mild: Once in a while, my eyelids feel slightly itchy, but I do not have a desire to rub them. (2) Moderate: Occasionally, my eyelids feel itchy, and I need to rub them. (3) Severe: It is difficult to relieve the sensation of itchiness even when I rub my eyelids. (4) Very severe: I have unbearable eyelid itching with an irresistible urge to rub my eyelids. Foreign body sensation/sandiness, grittiness: Do you feel like there’s something sandy or gritty in your eye? (0) None: My eyes do not feel sandy or gritty. (1) Mild: I am aware of the surface of my eyes once in a while. (2) Moderate: My eyes feel like there is something small in them occasionally. (3) Severe: My eyes feel like there is something large or gritty in them. (4) Very severe: I am unable to open my eyes due to feeling of a foreign body in myeyes. 4

Methods: Self Reported Patient Questions Ocular dryness: Are your eyes feeling dry? (0)None: My eyes do not feel dry. (1)Mild: I am aware of dryness to the point where I have to blink to feel better (2)Moderate: I am aware of dryness to the point where I desire to use artificial tears occasionally. (3)Severe: I am aware of dryness to the point where I desire to use artificial tears frequently. (4)Very severe: I am aware of dryness, to the point where I always desire to use artificial tears. Ocular burning or pain: Are your eyes burning or painful? (0)None: My eyes do not burn or ache. (1)Mild: I am aware of the surface of my eyes; they mildly burn or ache. (2)Moderate: I feel my eyes are burning, but still tolerable (3)Severe: My eyes feel throbbing or fiery due to burning/pain. (4)Very severe: I am unable to open my eyes due to burning/pain. 5

Methods: Masked Investigator Scoring Severity Plugging of the meibomian gland (in the middle part of lower lid, n=10) (0) Normal: Clear orifices of meibomian glands in the middle part of lower lid (n=0) (1) Mild: Less than 1/3 of orifices but at least one contain turbid secretions (n=1-3) (2) Moderate: Between 1/3 and 2/3 of orifices contain turbid secretions (n=4-6) (3) Severe: More than 2/3 of orifices but not all contain turbid secretions (n=7-9) (4) Very severe: All orifices plugged with turbid or coagulated secretions (n=10) Secretion expressed from the meibomian gland (0) Normal: Minimal clear, oily secretion (1) Mild: Cloudy secretion (2) Moderate: Granular secretion (3) Severe: Paste-like secretion (4) Obstructed: No expressible secretion 6

Methods: Masked Investigator Scoring Severity Lid debris (collarettes, clumps/strands) (0)Normal: Clear eyelid margin (1)Mild: Occasional fragment, 1-5 collarettes (2)Moderate: Few fragments, 6-20 collarettes (3)Severe: Many fragments, 21-40 collarettes (4)Very severe: Clumps/strands, >40 collarettes Eyelid margin erythema (0) Normal: Normal age-related redness and vasculature. (1) Mild:Slightly dilated blood vessels; vessels colored pink; present in the middle 2/3 section of the lower eyelid margin. (2) Moderate: More apparent dilation of blood vessels; vessel color more intense, whole margin of the eyelid is involved. (3)Severe: Increased vascularity of the eyelid margin, numerous and obvious dilated blood vessels, deep red in color, whole margin of the eyelid is involved. (4)Very severe: Clearly increased confluent vascularity of the eyelid margin; large, numerous dilated blood vessels characterized by deep red color, whole margin of the eyelid is involved. 7

Results: Demographics 50 patients: Sex: 21 male, 29 female Age: 78.1 ± 8.48 years AMD Status: Non-exudative (n = 21) Exudative (n = 29) 32% had a history of dry eye or blepharitis prior to examination 26% had a history of rosacae. 8

Results: Symptoms of Blepharitis by Patient Reported Survey Example: Eyelid Itching Patients reported the following symptoms: Eyelid itching – 1.2 Foreign body sensation – 1.1 Ocular dryness - 1.2 Ocular burning/pain – 1.1 Swollen heavy lids – 0.8. 9

Results: Signs of Blepharitis Masked Physician Recorded Symptoms: Lid debris – 1.5 Eyelid margin erythema – 1.7 Plugging of meibomian glands -1.5 Secretion expressed from the meibomian gland – 1.9. Example: Lid Debris 10

Results: Self-reported patient surveys and masked investigator examinations demonstrated similar-high prevalence of blepharitis (86% and 94% respectively). Fourteen percent of total patients reported no symptoms, and six percent had no clinical signs of blepharitis. Most patients had mild to moderate disease. The incidences were 50% and 36% for mild, 32% and 50% for moderate, and only 4% and 8% for severe symptoms and signs of blepharitis, respectively. Self-reported symptom scores were generally lower than clinical examination scores. The study strengths include that it was a prospective study, masked investigator, and patients were randomly chosen from AMD panel. The study weaknesses include that it was performed at a single site, by a single investigator. Adding photo grading by masked individuals may have improved the scientific method. 11

Conclusions: The prevalence of blepharitis is very high in the AMD patient population who may require frequent intravitreal injections. Prompt evaluation and control of blepharitis and close adherence to intravitreal injection guidelines may be suggested to minimize possible complication with endophthalmitis. 12